MENU
ATYR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
243.47M
P/E Ratio
N/A
Total Cash
72.13M
Projected Growth
N/A
Total Debt
13.28M
Revenue
235K
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
ATYR
Capitalization
243M
P/E Ratio
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash
72.1M
Total Cash/Share
0.81
Total Debt
13.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
235K
ROE
N/A
Book Value
70M
P/B Ratio
3.48
Cash Flow
N/A
Earnings
-0.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
84K
Current Ratio
5.48
Current Revenue Per Employee
3983.05
Dividends Per Share - Security
N/A
EBITDA
-66.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-58.88
Shares Held By Institutions
364M
Shares Outstanding - Current
88.9M
Total Liabilities
27M
Total Volume MTD
N/A
Value
-1
Gain YTD
-20.994
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information